Nima Nabavizadeh, M.D.
- Associate Professor of Radiation Medicine, School of Medicine
- Program Director, Radiation Oncology Residency Program, Radiation Medicine, School of Medicine
- Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine
Biography
Dr. Nima Nabavizadeh is an Associate Professor of Radiation Medicine at the Oregon Health & Science University (OHSU), where he holds multiple roles in patient care, cutting-edge research and medical education. With a specialization in the treatment of gastrointestinal cancers, lymphomas and hematologic malignancies, he is known for his compassionate and understandable approach to patient care and his commitment to delivering state-of-the-art radiation therapy, tailored to each patient's unique needs.
Dr. Nabavizadeh's commitment to advancing cancer care extends beyond clinical practice. In his role as the Chief Medical Officer within the Cancer Early Detection Advanced Research Center (CEDAR) at OHSU, he is at the forefront of innovative early detection research initiatives. He serves as the Principal Investigator for a multitude of cancer early detection clinical trials, exploring novel strategies and technologies for identifying cancer at its earliest stages.
As the Radiation Oncology Residency Program Director at OHSU, Dr. Nabavizadeh plays a pivotal role in shaping the future of radiation oncology. He is responsible for mentoring and educating the next generation of radiation oncologists, ensuring that they receive the highest level of training and exposure to diverse clinical scenarios.
Throughout his career, Dr. Nabavizadeh has garnered recognition for his contributions to the field of radiation oncology. He has authored numerous peer-reviewed publications, presented at national and international conferences, and received grants that underscore his dedication to patient care, resident education and innovative research.
Dr. Nabavizadeh was born and raised in Norman, Oklahoma, the home of the University of Oklahoma and where he majored in Mechanical Engineering. Beyond his professional endeavors, Dr. Nabavizadeh's heart lies with the great outdoors. His companion for these escapades is a vintage 1990 VW campervan, which has been transformed into a symbol of wanderlust and family adventures. As a hands-on enthusiast, he spends his downtime working on the mechanical intricacies of the campervan, ensuring that it's always ready for the next adventure.
Click here to listen to the pronunciation of Dr. Nabavizadeh's name.
Education and training
-
Degrees
- M.D., 2011, University of Oklahoma College of Medicine
-
Residency
- Radiation Oncology, Oregon Health and Science University, 2016
-
Fellowship
- Doris Duke Charitable Foundation Clinical Research Fellowship, University of California, San Francisco 2009
-
Certifications
- American Board of Radiology, 2017
Areas of interest
- Development of cancer detection tests
- Gastrointestinal cancers including esophageal, hepatobiliary, pancreatic, colorectal and anal
- Lymphoma and hematologic malignancies
Additional information
Publications
Elsevier pure profilePublications
Impact of Myc-Altered Pathology on Radiation Therapy Efficacy Among Patients With Relapsed/Refractory Large-B Cell Lymphoma
International Journal of Radiation Oncology Biology PhysicsLiver stereotactic body radiation therapy without fiducial or retained ethiodized oil guidance warrants greater than 5 mm planning target volumes
Journal of Medical Radiation SciencesPlasma cfDNA in Carcinoma of unknown primary
Current Problems in Cancer: Case ReportsPhase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma
Cancer medicineAngiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer
Cancer Biology and TherapyComparison of neoadjuvant regimens for resectable gastroesophageal junction cancer
Journal of Gastrointestinal OncologyConservative management of malignant colorectal polyps in select cases is safe in long-term follow-up
American journal of surgeryEarly Versus Late Recurrence in Rectal Cancer
Journal of Gastrointestinal SurgeryHepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases
Journal of surgical oncologyLow Utilization of External Beam Radiation Therapy for Patients With Unresectable Hepatocellular Carcinoma
International Journal of Radiation Oncology Biology PhysicsNeoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications
CancersThe Clinical and Economic Benefits Associated WithNovel Multi-Cancer Early Detection Tests:Conference Highlights from the 2022 ISPOR AnnualMeeting
American Journal of Managed CareApplication of ASCO Value Framework to Treatment Advances in Hepatocellular Carcinoma
JCO Oncology PracticeDegree of biliary tract violation during treatment of gallbladder adenocarcinoma is independently associated with development of peritoneal carcinomatosis
Journal of surgical oncologyGeographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma
Annals of surgical oncologyIncreasing Medical Student Engagement Through Virtual Rotations in Radiation Oncology
Advances in Radiation OncologyThe feasibility of patient-specific circulating tumor dna monitoring throughout multi-modality therapy for locally advanced esophageal and rectal cancer
DiagnosticsThermal ablation versus stereotactic body radiotherapy after transarterial chemoembolization for inoperable hepatocellular carcinoma
American Journal of RoentgenologyACR-ASTRO Practice Parameter for Image-guided Radiation Therapy (IGRT)
American Journal of Clinical Oncology: Cancer Clinical TrialsContrast-Enhanced Ultrasound to Detect Early Microvascular Changes in Skeletal Muscle after High-Dose Radiation Treatment
Radiation research